Erigeron canadensis
What's the taxonomical classification of Erigeron canadensis?
Erigeron canadensis belongs to the kingdom Plantae and is classified under the phylum Streptophyta. Within the class Equisetopsida and the subclass Magnoliidae, it is further organized into the order Asterales. This plant is a member of the family Asteraceae, placing it among the composite flowers, and is specifically categorized under the genus Erigeron, with its unique identity defined by the species canadensis.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Erigeron |
| Species | canadensis |
What are the morphological characteristics of this plant?
Erigeron canadensis has an erect, branching stem that typically reaches heights of 10 to 100 centimeters and is covered in fine, spreading hairs. The leaves are arranged alternately along the stem, transitioning from large, lanceolate basal leaves to smaller, sessile leaves toward the top. Small, white to lavender flower heads are clustered in terminal corymb-like cymes, each featuring numerous narrow ray florets surrounding a yellow disk. The phyllaries, or bracts located beneath the flower head, are distinctive because they are often tinged with purple and possess fine hairs. As the plant matures, it produces many small, wind-dispersed achenes equipped with a pappus of fine bristles.
What is the geographical distribution of this plant?
This plant is native to North America and is widely distributed across much of the continent, extending from southern Canada down through most of the United States. It has also become naturalized in many parts of Europe, Asia, and North Africa due to human activity. The species thrives in a variety of habitats, often colonizing disturbed soils, roadsides, and abandoned fields. Because of its adaptability, it can be found in both temperate and subtropical regions where moisture is available. Its ability to spread rapidly allows it to establish populations in diverse ecological zones across the globe.
How is this plant cultivated?
This plant Erigeron canadensis, commonly known as horseweed, grows most effectively in disturbed soils, roadsides, and agricultural fields where sunlight is abundant and competition is low.
It thrives in a wide range of soil types but prefers well-drained environments to prevent root rot. Because it is a prolific self-seeder, it can quickly colonize open ground once established. Cultivation for research or seed collection requires monitoring for moisture levels to ensure consistent germination.
Controlling its spread is often necessary when it appears in managed landscapes due to its aggressive growth habits.
What parts of this plant are used medicinally?
This plant Erigeron canadensis utilizes its flowers for various medicinal purposes in traditional practices. These small, daisy-like blooms are often harvested to create infusions or decoctions. Practitioners use these preparations to address issues related to inflammation or digestive discomfort. Some herbalists also value the plant for its potential to support respiratory health through the use of its floral components. By concentrating the active properties found in the flower, people have historically managed minor ailments with this common species.
According to a study published by "Journal of photochemistry and photobiology. B, Biology", the flowers of Erigeron canadensis L. (Ec) are used to isolate polyphenolic glycoconjugates. These glycoconjugates, along with their aglycones (EcA), were investigated for their radioprotective potential against gamma-radiation-induced lipid peroxidation in human plasma and DNA damage in lymphocytes. The study assessed properties by measuring the concentration of thiobarbituric acid reactive substances (TBARS) and using the alkaline comet assay. Results showed that applying EcA over Ec did not provide more benefit regarding lipid peroxidation inhibition. Additionally, the glycoconjugates Ec showed a much higher capacity in protecting lymphocytes against radiation-induced genotoxicity compared to the aglycones.
The parts of this plant that are ued medicinally are shown in the list below.
- flower
What traditional systems uses this plant?
This plant, Erigeron canadensis, has been utilized in various traditional medicinal systems to treat respiratory ailments, skin inflammations, and digestive issues.
In several folk medicine practices, decoctions made from the leaves and stems were historically administered to soothe coughs and alleviate symptoms of bronchitis. Indigenous groups sometimes applied poultices derived from the plant to topical wounds to promote healing and reduce swelling. Some historical records also suggest its use as a diuretic to support kidney function.
These diverse applications reflect its long-standing role in botanical remedies across different geographic regions.
What are the pharmacological activities of Erigeron canadensis?
This plant has anti-inflammatory, anti-platelet, anticoagulant, antitussive, and bronchodilator pharmacological activities. Its chemical constituents work to reduce swelling and modulate immune responses within the body. The plant also exhibits properties that inhibit platelet aggregation and prevent blood clotting processes. These specific effects make it useful for managing cardiovascular and respiratory conditions. Additionally, it serves as a remedy for cough suppression and the widening of airways during breathing difficulties.
According to a study published by "Biologia", Erigeron canadensis is recommended as a complementary supplementation for the treatment of diseases associated with immunological inflammation, such as the common cold, coughs, bronchitis, upper respiratory infections, and immunodeficiencies. The polyphenolic polysaccharide-proteins isolated from the flowers of Erigeron canadensis resulted in the significant immunostimulation of inflammatory TNF-α, IL-6, IL-1ß, and IL-12 cytokines (p < 0.001). These herbal polyphenolic polysaccharide-proteins also triggered the cell release of the anti-inflammatory interleukin IL-10 (p < 0.001). Furthermore, the inductive cell release of growth factors M-CSF and GM-CSF was demonstrated (p < 0.001). The polyphenolic polysaccharide-proteins of Erigeron canadensis accelerated the efficacy of cellular phagocytosis and free radical release, which was more pronounced with Erigeron treatment.
The primary pharmacological activities of this plant are shown in the list below.
- anti-inflammafory
- anti-platelet
- anticoagulant
- antitussive
- bronchodilator
What medicinal compounds this plant contains?
This plant contains phenolics, polyphenolic polysaccharide-protein (PPP) complex, polyphenolic polysaccharide-proteins, proteins, and uronic acids. These medicinal compounds contribute to the diverse biological activities observed in Erigeron canadensis. The presence of various proteins and uronic acids supports the structural and functional complexity of its chemical profile. Furthermore, the specialized polyphenolic polysaccharide-protein complexes play a significant role in its pharmacological properties. These combined substances work together to provide the plant with its unique therapeutic potential.
According to a study published by "Journal of ethnopharmacology", the Erigeron canadensis polyphenolic polysaccharide-protein complex is a dark brown substance with a molecular weight of 38,000 g/mol. This complex contains phenolics at 13.2% wt%, proteins at 16.3% wt%, and uronic acids at 6.3% wt%. The neutral carbohydrate portion consists mainly of galactose at 41.0 wt%, arabinose at 24.1 wt%, glucose at 13.3 wt%, and xylose at 12.1 wt%. Major polysaccharides identified within the Erigeron complex include arabinogalactan and 4-OMe-glucuronoxylan. These medicinal compounds exhibit a dose-dependent antitussive activity that approaches the effect of codeine.
The primary medicinal compounds of this plant are shown in the list below.
- phenolics
- polyphenolic polysaccharide-protein (PPP) complex
- polyphenolic polysaccharide-proteins
- proteins
- uronic acids
What health conditions is this plant used for?
This plant is used for treating acute lower respiratory tract infections, acute upper respiratory tract infections, bronchitis, the common cold, and cough. It contains bioactive compounds that help alleviate inflammation in the airway passages. People often utilize its medicinal properties to soothe persistent coughing and chest congestion. The plant serves as a traditional remedy to manage symptoms associated with various viral and bacterial respiratory illnesses. These applications make it a significant component in many herbal healing practices for respiratory health.
According to a study published by "Journal of ethnopharmacology", Erigeron canadensis has been used in traditional medicine to treat a variety of respiratory diseases, including acute upper and lower respiratory tract infections and cough-related asthma. The dark brown Erigeron complex has a molecular weight of 38,000 g/mol and contains phenolics at 13.2% wt%, proteins at 16.3% wt%, and uronic acids at 6.3% wt%. Its neutral carbohydrate part consists mainly of xylose at 12.1 wt%, glucose at 13.3 wt%, arabinose at 24.1 wt%, and galactose at 41.0 wt%. This plant complex exhibits dose-dependent antitussive activity that approaches the effect of codeine.
The main health conditions this plant is used for are shown in the list below.
- acute lower respiratory tract infections
- acute upper respiratory tract infections
- bronchitis
- common cold
- cough
What are the herbal preparations of this plant?
This plant is Erigeron canadensis, a species used to create medicinal herbal preparations such as polyphenolic-polysaccharide preparations that target various physiological functions. These specialized extracts concentrate the plant's bioactive compounds to enhance therapeutic efficacy. Researchers often study these specific preparations for their potential antioxidant and anti-inflammatory properties. Beyond these complex extracts, other traditional forms may include infusions or tinctures used for localized or systemic treatment. The chemical profile of the plant makes it a versatile subject for developing targeted herbal medicines.
According to a study published by "Thrombosis research", a polyphenolic-polysaccharide preparation isolated from Erigeron canadensis L. demonstrated in vivo anticoagulant and anti-platelet activity. The most active fraction of this plant preparation showed an anticoagulant activity of 7-9IU/mg of heparin standard when expressed in aPTT. The polysaccharide part of the conjugate constituted 32% of the total mass and possessed a molecular mass of 38kDa. This polysaccharide part contained mainly hexuronic acids along with smaller amounts of glucose, arabinose, galactose, mannose, xylose, and rhamnose. The polyphenolic part of the preparation had a molecular mass of >12.5kDa and was rich in hydroxylic and carboxylic groups.
The main herbal preparations of this plant are shown in the list below.
- polyphenolic-polysaccharide preparation
What side effects this plant can have?
This plant can induce anti-platelet activity which increases the risk of bleeding or bruising in humans. These physiological effects occur because specific chemical compounds in the species interfere with how blood cells clump together. Such properties can be dangerous for individuals already taking anticoagulant or anti-platelet medications. Furthermore, consuming the plant may cause unpredictable reactions in people with existing clotting disorders. Careful caution is necessary to avoid unintended medical complications during exposure.
According to a study published by "Thrombosis research", the polyphenolic-polysaccharide preparation from Erigeron canadensis L. demonstrated in vivo anticoagulant activity and anti-platelet activity limited to the cyclooxygenase pathway. A fraction of the plant with the highest anticoagulant activity showed 7-9IU/mg of heparin standard when expressed in aPTT. The polysaccharide part of the preparation constituted 32% of the total mass and had a molecular mass of 38kDa. Additionally, the polyphenolic part had a molecular mass >12.5kDa and was rich in hydroxylic rests and carboxylic groups. This preparation may become a new source of anticoagulant compound for anticoagulant and anti-platelet therapy.
The main side effects this plant can have are shown in the list below.
- anti-platelet activity
What herbs are paired with Erigeron canadensis?
This plant, Erigeron canadensis, pairs effectively with aromatic herbs like lavender, sage, and chamomile to enhance its subtle floral profile.
When grown in a garden setting, its fine-textured foliage provides a soft visual contrast to the bold, silvery leaves of sage. Pairing it with lavender creates a fragrant landscape that attracts a wide variety of pollinators to the area. Chamomile can be integrated nearby to complement the plant's delicate white flower heads.
These combinations work well together because they share similar sunlight and moisture requirements.